Medicare Enrolled
Dr. Waqas Rehman
Hematology & Oncology · Flemington, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rehman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rehman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rehman
Dr. Waqas Rehman is a hematology & oncology specialist in Flemington, NJ, with 17 years of NPI registration. Based on federal Medicare data, Dr. Rehman performed 129,700 Medicare services across 3,339 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rehman received a total of $9,799 from 88 pharmaceutical and/or device companies across 441 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rehman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 4% volume in NJ
$9,799 industry payments
Medicare Practice Summary
Medicare Utilization ↗129,700
Medicare services
Top 4% in NJ for hematology & oncology
3,339
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~7,629 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
71,250 | $1 | $4 |
| Anti-nausea injection (aprepitant) | 15,730 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 8,287 | $18 | $49 |
| Injection, granisetron, extended-release, 0.1 mg | 8,101 | $5 | $15 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
6,044 | $6 | $27 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
5,360 | $6 | $40 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,511 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,646 | $8 | $51 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,017 | $13 | $127 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
1,017 | $89 | $745 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
995 | $76 | $229 |
| Anti-nausea injection (Aloxi/palonosetron) | 880 | $1 | $39 |
| Anti-nausea injection (ondansetron/Zofran) | 848 | $0 | $1 |
| Injection, leucovorin calcium, per 50 mg | 537 | $3 | $24 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
507 | $121 | $1,023 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
392 | $27 | $661 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
333 | $2 | $13 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
328 | $10 | $164 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
312 | $2 | $20 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
309 | $6 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
259 | $8 | $24 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
254 | $7 | $32 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
248 | $5 | $22 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
240 | $109 | $323 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
229 | $59 | $691 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
158 | $158 | $518 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
130 | $46 | $157 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
126 | $1 | $1 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
110 | $26 | $572 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
108 | $61 | $497 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
99 | $1 | $4 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
98 | $14 | $145 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
95 | $69 | $309 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
94 | $69 | $235 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
92 | $12 | $661 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
78 | $18 | $674 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
65 | $32 | $269 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
61 | $2 | $12 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
49 | $18 | $123 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
46 | $73 | $365 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
44 | $52 | $416 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
42 | $31 | $551 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
41 | $109 | $476 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
40 | $1 | $11 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
36 | $147 | $592 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
35 | $19 | $90 |
| New patient office visit, complex (60-74 min) | 34 | $196 | $746 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
33 | $161 | $1,102 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
31 | $29 | $162 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
30 | $42 | $144 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
27 | $9 | $43 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
27 | $16 | $79 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
27 | $23 | $166 |
| Total calcium level test A blood test that measures the total amount of calcium in your body. |
26 | $5 | $50 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
25 | $5 | $50 |
| Blood urea nitrogen test A blood test that measures the amount of urea nitrogen to assess kidney function. |
25 | $4 | $50 |
| PSA test (prostate cancer screening) | 24 | $18 | $87 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
22 | $70 | $420 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
20 | $34 | $92 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 19 | $20 | $99 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
19 | $76 | $175 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
17 | $1 | $12 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
13 | $146 | $663 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
56.1% high complexity
39.9% medium
4.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,799
Total received (2018-2024)
Avg $1,400/year across 7 years
Top 28% in NJ for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
88
Companies
441
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,690 (68.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,709 (17.4%)
Other
Charitable contributions, space rental, and other categories
$1,217 (12.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$183 (1.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,805
2023
$1,749
2022
$829
2021
$2,337
2020
$570
2019
$673
2018
$837
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,217
AstraZeneca Pharmaceuticals LP
$174
GENZYME CORPORATION
$139
ABBVIE INC.
$93
Daiichi Sankyo Inc.
$78
BeiGene USA, Inc.
$57
Lilly USA, LLC
$57
Eisai Inc.
$55
Astellas Pharma US Inc
$55
Tempus AI, Inc
$53
GlaxoSmithKline, LLC.
$51
Genentech USA, Inc.
$49
E.R. Squibb & Sons, L.L.C.
$48
ARRAY BIOPHARMA INC
$40
Regeneron Healthcare Solutions, Inc.
$40
Genmab U.S., Inc.
$38
Adaptive Biotechnologies Corporation
$37
Janssen Pharmaceuticals, Inc
$37
SERVIER PHARMACEUTICALS LLC
$37
Gilead Sciences, Inc.
$36
Janssen Biotech, Inc.
$34
SpringWorks Therapeutics, Inc.
$34
Aveo Pharmaceuticals, Inc.
$32
PFIZER INC.
$32
Sandoz Inc.
$30
TAIHO ONCOLOGY, INC.
$21
SOBI, INC
$19
Ipsen Biopharmaceuticals, Inc
$19
Celltrion USA Inc.
$19
Fresenius Kabi USA, LLC
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Karyopharm Therapeutics Inc.
$17
Kyowa Kirin, Inc.
$17
Incyte Corporation
$17
Stemline Therapeutics Inc.
$15
Blueprint Medicines Corporation
$15
Celgene Corporation
$15
Dendreon Pharmaceuticals LLC
$15
Bayer Healthcare Pharmaceuticals Inc.
$15
Takeda Pharmaceuticals U.S.A., Inc.
$15
Top 3 companies account for 54.5% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,048
Novartis Pharmaceuticals Corporation
$1,505
Janssen Biotech, Inc.
$648
GENZYME CORPORATION
$305
Amgen Inc.
$223
PFIZER INC.
$219
Daiichi Sankyo Inc.
$215
Incyte Corporation
$214
Lilly USA, LLC
$214
E.R. Squibb & Sons, L.L.C.
$209
Genentech USA, Inc.
$196
Stemline Therapeutics Inc.
$176
Celltrion USA Inc.
$169
Astellas Pharma US Inc
$162
Janssen Pharmaceuticals, Inc
$161
Celgene Corporation
$151
Gilead Sciences, Inc.
$151
ABBVIE INC.
$139
Takeda Pharmaceuticals U.S.A., Inc.
$135
Regeneron Healthcare Solutions, Inc.
$134
Eisai Inc.
$124
GlaxoSmithKline, LLC.
$94
BeiGene USA, Inc.
$91
Coherus Biosciences Inc.
$81
ARRAY BIOPHARMA INC
$69
MorphoSys, US Inc.
$68
Bayer HealthCare Pharmaceuticals Inc.
$65
Kyowa Kirin, Inc.
$63
Seagen Inc.
$62
Ipsen Biopharmaceuticals, Inc
$62
SERVIER PHARMACEUTICALS LLC
$58
GE HealthCare
$57
Foundation Medicine, Inc.
$57
Genmab U.S., Inc.
$55
Tempus AI, Inc
$53
Kite Pharma, Inc.
$51
Fresenius Kabi USA, LLC
$43
EISAI INC.
$43
Heron Therapeutics, Inc.
$41
Roche Diagnostics Corporation
$40
Merck Sharp & Dohme Corporation
$40
Covidien LP
$39
TAIHO ONCOLOGY, INC.
$39
Pharmacyclics LLC, An AbbVie Company
$38
Adaptive Biotechnologies Corporation
$37
Epizyme, Inc.,
$37
Janssen Scientific Affairs, LLC
$34
SpringWorks Therapeutics, Inc.
$34
Rigel Pharmaceuticals, Inc.
$34
Seattle Genetics, Inc.
$33
Aveo Pharmaceuticals, Inc.
$32
Apellis Pharmaceuticals, Inc.
$32
Bard Peripheral Vascular, Inc.
$31
Servier Pharmaceuticals LLC
$31
Alexion Pharmaceuticals, Inc.
$31
Exelixis Inc.
$31
Sandoz Inc.
$30
Blueprint Medicines Corporation
$30
Dendreon Pharmaceuticals LLC
$30
EMD Serono, Inc.
$29
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Pharmacyclics LLC, an AbbVie Company
$28
Sumitomo Pharma America, Inc.
$27
Alnylam Pharmaceuticals Inc.
$27
AbbVie Inc.
$27
SOBI, INC
$19
Agios Pharmaceuticals, Inc.
$19
SECURA BIO, INC.
$19
Pharmacosmos Therapeutics Inc.
$18
Karyopharm Therapeutics Inc.
$17
PUMA BIOTECHNOLOGY, INC.
$15
Puma Biotechnology, Inc.
$15
Sobi, Inc
$15
Bayer Healthcare Pharmaceuticals Inc.
$15
Myovant Sciences Inc.
$15
Mirati Therapeutics, Inc.
$15
MEDIVATION FIELD SOLUTIONS LLC
$15
TESARO, Inc.
$14
ACCORD HEALTHCARE, INC.
$14
Clovis Oncology, Inc.
$14
Taiho Oncology, Inc.
$14
EUSA Pharma (US) LLC
$14
AMAG Pharmaceuticals, Inc.
$13
Dova Pharmaceuticals
$12
Octapharma USA, Inc.
$12
AbbVie, Inc.
$12
SANOFI-AVENTIS U.S. LLC
$12
Secura Bio, Inc.
$10
Top 3 companies account for 42.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AYVAKIT · Aliqopa · BAVENCIO · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABOMETYX · CALQUENCE · CAMCEVI · CINVANTI · COPIKTRA · Cabometyx · Columvi · DARZALEX · DIS Navify Software · DOPTELET · DUPIXENT · Doptelet · ELAHERE · ELITEK · EMEND · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Empaveli · Enhertu · Epkinly · Erivedge · Erleada · FARYDAK · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · GAZYVA · GILOTRIF · GIVLAARI · GIVLARRI · GLASSIA · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · JADENU · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NETSPOT · NINLARO · Neulasta · Nubeqa · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Pomalyst · Poteligeo · REBLOZYL · RECOTHROM · RETEVMO · Revlimid · Rubraca · SANDOSTATIN · SARCLISA · SOLIRIS · SUSTOL · SUTENT · Somatuline Depot · Stimufend · Stivarga · SuperDimension · Sylvant · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · ULTRACOR · Udenyca · VEGZELMA · VENCLEXTA · VERZENIO · Venclexta · Voranigo · Vyloy · XALKORI · XARELTO · XPOVIO · XT CDX · XTANDI · Xtandi · Yescarta · ZARXIO · ZEJULA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (68%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
81
Per 100K population
62.6
County median income
$139,453
Nearest hospital
HUNTERDON MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rehman is a mixed practice specialist, with above-average Medicare volume (top 4% in NJ), with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rehman experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Rehman performed 71,250 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rehman receive payments from pharmaceutical companies?
Yes. Dr. Rehman received a total of $9,799 from 88 companies across 441 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rehman's costs compare to other hematology & oncology specialists in Flemington?
Dr. Rehman's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rehman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Flemington
Browse hematology & oncology specialists in Flemington ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NJ
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NJ
Which NJ hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology